首页> 外文期刊>AJNR. American journal of neuroradiology >Distinguishing recurrent primary brain tumor from radiation injury: a preliminary study using a susceptibility-weighted MR imaging-guided apparent diffusion coefficient analysis strategy.
【24h】

Distinguishing recurrent primary brain tumor from radiation injury: a preliminary study using a susceptibility-weighted MR imaging-guided apparent diffusion coefficient analysis strategy.

机译:区分复发性原发性脑肿瘤与放射损伤:使用药敏加权MR成像引导的表观扩散系数分析策略进行的初步研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: The accurate delineation of tumor recurrence presents a significant problem in neuro-oncology. Our aim was to improve the identification of brain tumor recurrence from chemoradiation injury by using CE-SWI, a technique that provides improved visualization of the heterogeneous patterns of brain tumor pathology, to guide the analysis of ADC measures within the peritumoral territory. MATERIALS AND METHODS: Seventeen patients who were being treated for high-grade glial neoplasms took part in the study. All patients presented with new enhancing lesions on follow-up CE-T1. Recurrence or chemoradiation injury was confirmed from either histologic analysis or extensive clinical follow-up. Regions of enhancement on registered CE-SWI and CE-T1 images were extracted in a semiautomated fashion and transferred to co-registered ADC maps. Significant differences in ADC measures defined within the enhancement volumes on serial MR images were analyzed by using a nonparametric Kolmogorov-Smirnov approach and correlated with clinical follow-up diagnoses. RESULTS: Analysis of the serial data revealed that patients with a diagnosis of tumor recurrence had significantly reduced ADC measures within the enhancement volume delineated on CE-SWI. In contrast, patients with SD had significantly elevated ADC within the CE-SWI enhancement volume. CONCLUSIONS: The findings of an increase in enhancement volume delineated on serial CE-SWI maps, along with a concomitant reduction in ADC within this volume for patients with recurrent tumor, provide support for such an approach to be used to assist in follow-up patient management strategies.
机译:背景与目的:准确描述肿瘤复发是神经肿瘤学中的重要问题。我们的目标是通过使用CE-SWI改进对化学放疗损伤后脑肿瘤复发的鉴定,该技术可改善脑肿瘤病理学的异质性模式的可视化,从而指导在肿瘤周围区域内ADC措施的分析。材料与方法:接受高级别神经胶质瘤治疗的17名患者参加了该研究。所有患者在随访CE-T1时均出现新的增强病变。从组织学分析或广泛的临床随访中证实了复发或化学放射损伤。以半自动化的方式提取已注册的CE-SWI和CE-T1图像上的增强区域,并将其转移到共同注册的ADC映射中。通过使用非参数Kolmogorov-Smirnov方法分析了在串行MR图像上增强量内定义的ADC测量的显着差异,并与临床随访诊断相关。结果:对系列数据的分析显示,诊断出肿瘤复发的患者在CE-SWI规定的增强量范围内,ADC措施明显减少。相反,SD患者在CE-SWI增强量范围内ADC明显升高。结论:一系列CE-SWI图上描述的增强体积增加的发现,以及伴随复发肿瘤患者在该体积内ADC的同时减少,为这种方法用于辅助随访患者提供了支持。管理策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号